IV Therapy in 2026: New Research, Rules, and Market Data

Intravenous (IV) therapy keeps getting more popular, and 2026 has quietly become the year the science, the regulators, and the market data all caught up with the trend at the same time. Below is a plain-English roundup of the most important IV therapy news so far this year, what each development means, and the questions worth asking before you book a drip.

This is a news summary from the TheDripMap team, not medical advice. Always talk to a qualified clinician about your own health.

Key takeaways

The global IV hydration therapy market was worth about 2.83 billion dollars in 2025 and is projected to reach 5.66 billion by 2033, a yearly growth rate of roughly 9 percent, according to Grand View Research.
A Yale research team reported in late 2025 that IV hydration spas are lightly regulated and that oversight varies widely from one state to the next.
In February 2026, Kansas health regulators warned that many retail IV clinics may be breaking the law when unlicensed staff administer drips.
A 2026 systematic review found limited high-quality evidence behind NAD+ anti-aging claims, while not finding the infusions unsafe for healthy adults.
The thread running through every story is the same: who prescribes and supervises your drip matters more than which items are on the menu.

The market is still booming

Demand has not slowed. Grand View Research valued the global IV hydration therapy market at about 2.83 billion dollars in 2025 and projects it will reach 5.66 billion dollars by 2033, growing at a compound annual rate of 9.2 percent. The picture is similar in Europe, where Coherent Market Insights estimates the market at 616.7 million dollars in 2026, more than doubling by 2033, with energy and recovery drips making up the largest single segment.

For context on how mainstream this has become, a JAMA Medical News feature noted that the wider medical spa market already counted nearly 9,000 facilities as far back as 2022, many of them now offering vitamin drips alongside aesthetic services.

The real headline is oversight, not ingredients

The biggest theme of 2026 is not a new vitamin blend. It is the growing attention to how these clinics are run.

A team at the Yale School of Medicine, led by Professor Howard Forman, published research in late 2025 finding that state-level policies for IV hydration spas vary widely and that many operate with very little oversight. The researchers cautioned that some offerings are unproven, and that consumers should be careful about paying high fees for services that look clinical but are lightly regulated.

A companion JAMA feature, asking directly whether these spas are safe, raised the same core question: the treatments are heavily marketed and celebrity-backed, but the rules that govern who can offer them, and how, are inconsistent.

The concern is not unique to the United States. A British Columbia Medical Journal editorial described Canadian IV spas as operating in a grey zone, under a patchwork of provincial colleges and Health Canada rules, with some clinics functioning in practice like compounding pharmacies but without the same oversight.

Regulators are starting to act

The clearest example came from Kansas. On February 25, 2026, the state's healing arts and pharmacy boards issued a joint warning that many retail IV therapy clinics are likely violating the law. Under Kansas law, IV therapy is the practice of medicine, so only licensed professionals with prescribing authority may diagnose, prescribe, and oversee treatment.

Regulators flagged two practices in particular: letting unqualified staff administer drips, and letting customers pick their own infusion from a menu. As the boards put it, "Prescriber involvement cannot be obviated by letting the patient direct their own care."

The takeaway for patients is simple. A real clinician should be involved in deciding whether a drip is appropriate for you, not just present somewhere in the building.

The NAD+ evidence check

NAD+ (nicotinamide adenine dinucleotide) drips have been one of the most hyped, and most expensive, items on clinic menus, with sessions ranging from promotional rates near 79 dollars to as much as 1,000 dollars. NAD+ is a coenzyme found in every cell that helps turn food into energy and supports DNA repair, which is why anti-aging clinics have built a strong pitch around it.

A peer-reviewed systematic review published in early 2026, reported by the News and Observer, screened studies from 2010 through 2025. Its conclusion cut against the marketing: there is limited high-quality evidence that NAD+ infusions deliver the anti-aging benefits often promised. Importantly, the review did not find the infusions dangerous for healthy adults. The gap it identified was in proof of benefit, not a specific safety alarm.

What this means if you are booking IV therapy

None of this means IV therapy is a scam, and none of it is medical advice. It means the quality of the clinic matters more than the trend. Based on what regulators and researchers emphasized this year, here is what to look for:

A licensed clinician reviews your health before you receive anything, rather than a self-serve menu.
The clinic is transparent about who prescribes the drip and who administers it.
The clinic can answer basic questions about ingredient sourcing and medical oversight.

If you want a deeper checklist, see our guide on the questions to ask before IV therapy and our overview of common treatment protocols. When you are ready to compare options, you can find a clinic near you or browse by city.

On TheDripMap, clinics that complete our safety questionnaire show a Safety Verified marker, so you can see at a glance which providers have documented their medical oversight. TheDripMap is a matching platform, and we do not provide treatment or medical advice.

Frequently asked questions

Is IV therapy safe in 2026?

The procedure itself is well established in medicine, but safety in a retail spa setting depends heavily on oversight. In 2026, both researchers at Yale and regulators in states like Kansas stressed that risk rises when unlicensed staff administer drips or when patients choose infusions without a clinician's involvement. Choosing a clinic with clear medical supervision is the most important safety factor. This is general information, not medical advice.

Is NAD+ IV therapy proven to slow aging?

Not according to the latest review. A peer-reviewed systematic review published in early 2026 found limited high-quality evidence that NAD+ infusions deliver the anti-aging benefits often advertised. The same review did not find the infusions unsafe for healthy adults. If you are considering NAD+, discuss realistic expectations and costs with a qualified clinician first.

Why are regulators warning about IV hydration spas?

Research from Yale found that oversight of IV hydration spas varies widely by state and is often light. In February 2026, Kansas health boards warned that many retail clinics may be operating illegally when unlicensed staff administer drips or when customers select their own infusions. The core issue is medical supervision, not the vitamins themselves.

How big is the IV therapy industry in 2026?

The global IV hydration therapy market was valued at about 2.83 billion dollars in 2025 and is projected to reach 5.66 billion dollars by 2033, growing roughly 9.2 percent per year, according to Grand View Research. In Europe, Coherent Market Insights estimates the market at about 616.7 million dollars in 2026.

How do I choose a safe IV therapy clinic?

Look for a licensed clinician who reviews your health before treatment, transparency about who prescribes and administers the drip, and clear answers about ingredient sourcing. On TheDripMap, providers that complete a safety questionnaire display a Safety Verified marker so you can compare oversight at a glance.